Changing Our Minds: Reforming the FDA Medical Device Reclassification Process
Food and Drug Law Journal | Volume 73 | Number 1
Kid Tested, FDA Approved: Examining Pediatric Drug Testing
Food and Drug Law Journal | Volume 72 | Number 4
Get Real: Organic Marketing Under USDA’s Proposed Promotion & Research Agreement
Food and Drug Law Journal | Volume 72 | Number 4
When the Alpha is the Omega: P-Values, “Substantial Evidence,” and the 0.05 Standard at FDA GalleryWhen the Alpha is the Omega: P-Values, “Substantial Evidence,” and the 0.05 Standard at FDA
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 72.4
When the Alpha is the Omega: P-Values, “Substantial Evidence,” and the 0.05 Standard at FDA
Food and Drug Law Journal | Volume 72 | Number 4
Brand Name Preemption: The New Frontier In Pharmaceutical Product Liability Litigation
Food and Drug Law Journal | Volume 72 | Number 4
- Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision Gallery
Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 72.4
Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision
Food and Drug Law Journal | Volume 72 | Number 4
Letter to the Editor
Food and Drug Law Journal | Volume 72 | Number 4
- Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD (Open Access) Gallery
Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD (Open Access)
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Food, Dietary Supplements, Cosmetics, Publications, Tobacco Products, Volume 72.3
Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD (Open Access)
Food and Drug Law Journal | Volume 72 | Number 3
Communicating Tobacco Product Information to the Public
Food and Drug Law Journal | Volume 72 | Number 3
- The Role of Patient Participation in Drug Approvals: Lessons from the Accelerated Approval of Eteplirsen (Open Access) Gallery
The Role of Patient Participation in Drug Approvals: Lessons from the Accelerated Approval of Eteplirsen (Open Access)
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 72.3
The Role of Patient Participation in Drug Approvals: Lessons from the Accelerated Approval of Eteplirsen (Open Access)
Food and Drug Law Journal | Volume 72 | Number 3
